33,961 research outputs found

    Neutral and Cationic Bis-Chelate Monoorganosilicon(IV) Complexes of 1-Hydroxy-2-pyridinone

    Get PDF
    A series of spirocyclic monoorganosilicon compounds of the form RSi(OPO)2Cl [R = phenyl (1); p-tolyl (2); benzyl (3); Me (4); tBu (5); thexyl (6)] (OPO = 1-oxo-2-pyridinone) was synthesized and characterized by 1H , 13C, and 29Si NMR spectroscopy, X-ray crystallography, and elemental analysis. In the solid state, complexes 1, 2, and 3 are neutral and possess cis-OPO ligands in an octahedral arrangement, and complexes 4, 5, and 6 are cationic and possess effectively trans­-OPO ligands in nearly ideal square pyramidal geometries along the Berry-pseudorotation coordinate. In 4-6, chloride dissociation is attributed to the additive effect of multiple intermolecular C—H∙∙∙Cl interactions in their crystals. In DMSO-d6 solution, compounds 1-6 form cationic hexacoordinate DMSO adducts with trans-OPO ligands, all of which undergo dynamic isomerization with energy barriers of ~18-19 kcal/mol. Compounds with better leaving groups, (p-tolyl)Si(OPO)2X [X = I (7); X = triflate (8)], exhibit identical solution NMR spectra as 2, supporting anion dissociation in each. The fluoride derivatives RSi(OPO)2F [R = benzyl (9); Me (10)] exhibit hexacoordinate geometries with cis­-OPO ligands in the solid state and exhibit dynamic isomerization in solution. Overall, these studies indicate, in both the solid and solution states, that the trans-OPO ligand arrangement is favored when anions are dissociated and a cis­-OPO ligand arrangement when anions are coordinated

    Computationally motivated synthesis and enzyme kinetic evaluation of N-(β-d-glucopyranosyl)-1,2,4-triazolecarboxamides as glycogen phosphorylase inhibitors

    Get PDF
    Following our recent study of N-(β-D-glucopyranosyl)-oxadiazole-carboxamides (Polyák et al., Biorg. Med. Chem. 2013, 21, 5738) revealed as moderate inhibitors of glycogen phosphorylase (GP), in silico docking calculations using Glide have been performed on N-(β-D-glucopyranosyl)-1,2,4-triazolecarboxamides with different aryl substituents predicting more favorable binding at GP. The ligands were subsequently synthesized in moderate yields using N-(2,3,4,6-terta-O-acetyl-β-D-glucopyranosyl)-tetrazole-5-carboxamide as starting material. Kinetics experiments against rabbit muscle glycogen phosphorylase b (RMGPb) revealed the ligands to be low µM GP inhibitors; the phenyl analogue (Ki = 1 µM) is one of the most potent N-(β-D-glucopyranosyl)-heteroaryl-carboxamide-type inhibitors of the GP catalytic site discovered to date. Based on QM and QM/MM calculations, the potency of the ligands is predicted to arise from favorable intra- and intermolecular hydrogen bonds formed by the most stable solution phase tautomeric (t2) state of the 1,2,4-triazole in a conformationally dynamic system. ADMET property predictions revealed the compounds to have promising pharmacokinetic properties without any toxicity. This study highlights the benefits of a computationally lead approach to GP inhibitor design

    Organoaluminium complexes of ortho-, meta-, para-anisidines: synthesis, structural studies and ROP of ε-caprolactone (and rac-lactide)

    Get PDF
    Reaction of Me₃Al (two equivalents) with ortho-, meta- or para-anisidine, (OMe)(NH₂)C₆H₄, affords the complexes {[1,2-(OMe),NC₆H₄(μ-Me₂Al)](μ-Me₂Al)}₂ (1), [1,3-(Me₃AlOMe),NHC₆H₄(μ-Me₂Al)]2 (2) or [1,4-(Me₃AlOMe),NHC₆H₄(μ-Me₂Al)]₂ (3), respectively. The molecular structures of 1–3 have been determined and all three complexes were found to be highly active for the ring opening polymerization (ROP) of ε-caprolactone. 1 was found highly active either with or without benzyl alcohol present; at various temperatures, the activity order 1 > 2 ≈ 3 was observed. For the ROP of rac-lactide results for 1–3 were poor
    corecore